The 'Treg paradox' in inflammatory arthritis
- PMID: 39653758
- DOI: 10.1038/s41584-024-01190-w
The 'Treg paradox' in inflammatory arthritis
Abstract
Classic regulatory T (Treg) cells expressing CD4 and the hallmark transcription factor FOXP3 are integral to the prevention of multi-system autoimmunity. However, immune-mediated arthritis is often associated with increased numbers of Treg cells in the inflamed joints. To understand these seemingly conflicting observations, which we collectively describe as 'the Treg paradox', we provide an overview of Treg cell biology with a focus on Treg cell heterogeneity, function and dysfunction in arthritis. We discuss how the inflamed environment constrains the immunosuppressive activity of Treg cells while also promoting the differentiation of TH17-like Treg cell, exTreg cell (effector T cells that were formerly Treg cells), and osteoclastogenic Treg cell subsets that mediate tissue injury. We present a new framework to understand Treg cells in joint inflammation and define potential strategies for Treg cell-directed interventions in human inflammatory arthritis.
© 2024. Springer Nature Limited.
Conflict of interest statement
Competing interests: L.A.H. has received salary support from the Childhood Arthritis and Rheumatology Research Alliance (CARRA); investigator-initiated research grants from BMS; and consulting fees from Sobi, Pfizer and Adaptive Biotechnologies. F.v.W. has previously served as a speaker and/or consultant for Janssen, Johnson & Johnson and Takeda, and has received grants from Regeneron Pharmaceuticals, LEO Pharma, Sanofi, BMS, Galapagos and Takeda. P.A.N. declares consulting relationships with Alkermes, Apollo, BMS, Exo Therapeutics, Fresh Tracks Therapeutics, Merck, Novartis, Pfizer, Qiagen and Sobi; equity in Edelweiss Immune Inc.; investigator-initiated research grants from BMS and Pfizer; and authorship and editorial income from UpToDate, the American Academy of Paediatrics and Arthritis & Rheumatology. All other authors declare no competing interests.
Similar articles
-
Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis.Nat Med. 2014 Jan;20(1):62-8. doi: 10.1038/nm.3432. Epub 2013 Dec 22. Nat Med. 2014. PMID: 24362934
-
The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells.Nat Immunol. 2017 Jul;18(7):800-812. doi: 10.1038/ni.3748. Epub 2017 May 15. Nat Immunol. 2017. PMID: 28504697
-
FOXP3 and RORγt: transcriptional regulation of Treg and Th17.Int Immunopharmacol. 2011 May;11(5):536-42. doi: 10.1016/j.intimp.2010.11.008. Epub 2010 Nov 23. Int Immunopharmacol. 2011. PMID: 21081189 Review.
-
Regulatory role of PI16 in autoimmune arthritis and intestinal inflammation: implications for Treg cell differentiation and function.J Transl Med. 2024 Apr 2;22(1):327. doi: 10.1186/s12967-024-05082-1. J Transl Med. 2024. PMID: 38566233 Free PMC article.
-
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer.Immunity. 2019 Feb 19;50(2):302-316. doi: 10.1016/j.immuni.2019.01.020. Immunity. 2019. PMID: 30784578 Review.
Cited by
-
Understanding rheumatic disease through continuous cell state analysis.Nat Rev Rheumatol. 2025 Jun;21(6):323-335. doi: 10.1038/s41584-025-01253-6. Epub 2025 May 7. Nat Rev Rheumatol. 2025. PMID: 40335652 Review.
-
Biomaterials for Modulating the Immune Microenvironment in Rheumatoid Arthritis.BME Front. 2025 Mar 10;6:0102. doi: 10.34133/bmef.0102. eCollection 2025. BME Front. 2025. PMID: 40065832 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials